Third mRNA COVID-19 Vaccine Helps Some Patients With Blood Cancer Produce Antibodies for First Time
December 18th 2021There are 2 such vaccines now in use in the United States; the Pfizer-BioNTech vaccine is fully approved for the first 2 doses for those 16 and older, and the Moderna vaccine has an emergency use authorization for those 18 and older.
Read More
New Imaging Approach May Assess Disease Burden in Patients With SMA
December 18th 2021If further studies confirm a benefit by using Multispectral Optoacoustic Tomography (MSOT), the technology can help forge a path toward a noninvasive, bedside, nonionizing approach to early visualization of disease as well as evaluation of disease burden and disease progression in patients.
Read More
Dr Daniel Greer Discusses the Evolution of CBT Capabilities in Chronic Insomnia
December 17th 2021Daniel Greer, PharmD, BCPP, clinical assistant professor, Rutgers Ernest Mario School of Pharmacy, speaks on how capabilities of cognitive behavioral therapy have evolved to a more user-friendly approach in the management of chronic insomnia.
Watch
Dialysis Modality Influenced Degree of Pandemic-Related Psychological Distress in Patients With CKD
December 17th 2021Patients with chronic kidney disease (CKD) undergoing hemodialysis experienced a greater degree of psychological distress during the COVID-19 pandemic compared with patients treated with peritoneal dialysis, investigators found.
Read More
Dr David R. Stukus on Immune-Related Response to Therapy in Atopic Dermatitis
December 17th 2021David R. Stukus, MD, FACAAI, of Nationwide Children's Hospital and The Ohio State University College of Medicine, and a board member of the American College of Allergy, Asthma & Immunology, discusses efforts to align novel treatments for atopic dermatitis with patients based on the underlying mechanisms of disease.
Watch
Daratumumab-Led Quad Therapy Aids MRD Surveillance in MM
December 17th 2021Final results from the MASTER trial presented at this year’s 63rd Annual American Society of Hematology Annual Meeting and Exposition bear out the benefits of quadruplet therapy and using minimal residual disease (MRD) status among patients with newly diagnosed multiple myeloma (MM).
Read More
What We're Reading: J&J Blood Clot Concerns; Abortion Pill Access; Pandemic Health Spending
December 17th 2021The CDC is recommending that people at risk of developing blood clots receive the Moderna or Pfizer/BioNTech vaccines instead of Johnson & Johnson (J&J); the FDA lifts restrictions on mail order access to abortion pills; US health care spending more than doubled during the first year of the pandemic.
Read More
Contributor: Should Insurance Regulation Be Used to Promote Nontraditional Goals?
December 17th 2021Three policies to revamp insurance consumer protections for health care delivery are explored, with highlighted areas for improvement being maternal health coverage and loosening of network adequacy requirements.
Read More
Findings Are Reported From De-escalation Therapy in Early Breast Cancer
December 15th 2021Investigators said pathologic complete response was higher with a molecularly selected subgroup of patients with early-stage breast cancer treated with a nonchemotherapy combination that included a trastuzumab biosimilar.
Read More
Comparing QOL Among Women With Infertility, PCOS, Obesity
December 15th 2021Results of a secondary analysis indicate anxiety, depression, physical quality of life (QOL), and sexual function in obese infertile woman with polycystic ovary syndrome (PCOS) seem to be more related to obesity rather than PCOS status.
Read More
Comorbid Psoriasis, NAFLD Linked With Significantly Impaired Kidney Function
December 15th 2021Patients with comorbid nonalcoholic fatty liver disease (NAFLD) and chronic plaque psoriasis were shown to have significantly lower estimated glomerular filtration rate levels and greater prevalence of more advanced chronic kidney disease.
Read More
The Omicron variant may cause a wave of infections as soon as January 2022; Pfizer’s COVID-19 pill, Paxlovid, was found to reduce the risk of hospitalization and death by 88%; JPMorgan Health Care Conference will move to a virtual format after receiving pressure from major drug companies.
Read More
Comparable, Sustained Efficacy Observed With HNS vs PAP Therapy in OSA
December 15th 2021Patients with obstructive sleep apnea (OSA) exhibited similarly improved insomnia and quality-of-life outcomes when administered hypoglossal nerve stimulation (HNS) vs standard-of-care positive airway pressure (PAP) therapy.
Read More